Cargando…

Combined APRI/ALBI score to predict mortality after hepatic resection

BACKGROUND: Aspartate aminotransferase/platelet ratio index (APRI) and albumin–bilirubin grade (ALBI) are validated prognostic indices implicated as predictors of postoperative liver dysfunction after hepatic resection. The aim of this study was to evaluate the relevance of the combined APRI/ALBI sc...

Descripción completa

Detalles Bibliográficos
Autores principales: Starlinger, P, Ubl, D S, Hackl, H, Starlinger, J, Nagorney, D M, Smoot, R L, Habermann, E B, Cleary, S P
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7893465/
https://www.ncbi.nlm.nih.gov/pubmed/33609383
http://dx.doi.org/10.1093/bjsopen/zraa043
_version_ 1783653056040140800
author Starlinger, P
Ubl, D S
Hackl, H
Starlinger, J
Nagorney, D M
Smoot, R L
Habermann, E B
Cleary, S P
author_facet Starlinger, P
Ubl, D S
Hackl, H
Starlinger, J
Nagorney, D M
Smoot, R L
Habermann, E B
Cleary, S P
author_sort Starlinger, P
collection PubMed
description BACKGROUND: Aspartate aminotransferase/platelet ratio index (APRI) and albumin–bilirubin grade (ALBI) are validated prognostic indices implicated as predictors of postoperative liver dysfunction after hepatic resection. The aim of this study was to evaluate the relevance of the combined APRI/ALBI score for postoperative clinically meaningful outcomes. METHODS: Patients undergoing hepatectomy were included from the American College of Surgeons National Surgical Quality Improvement Program database. The association between APRI/ALBI score and postoperative grade C liver dysfunction, liver dysfunction-associated and overall 30-day mortality was assessed. RESULTS: A total of 12 055 patients undergoing hepatic resection from 2014 to 2017 with preoperative blood values and detailed 30-day postoperative outcomes were included (exploration cohort: January 2014 to December 2016; validation cohort: 2017). In the exploration cohort (8538 patients), the combination of both scores (APRI/ALBI) was significantly associated with postoperative grade C liver dysfunction, 30-day mortality, and liver dysfunction-associated 30-day mortality, and was superior to either score alone. The association with postoperative 30-day mortality was confirmed in multivariable analysis. A predictive model was generated using the exploration cohort. The predicted incidence of events closely followed the observed incidence in the validation cohort (3517 patients). Subgroup analyses of tumour types were used to generate disease-specific risk models to assess risk in different clinical scenarios. These findings informed development of a smartphone application (https://tellaprialbi.37binary.com). CONCLUSION: The predictive potential of the combined APRI/ALBI score for clinically relevant outcomes such as mortality was demonstrated. An evidence-based smartphone application will allow clinical translation and facilitation of risk assessment before hepatic resection using routine laboratory parameters.
format Online
Article
Text
id pubmed-7893465
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-78934652021-02-24 Combined APRI/ALBI score to predict mortality after hepatic resection Starlinger, P Ubl, D S Hackl, H Starlinger, J Nagorney, D M Smoot, R L Habermann, E B Cleary, S P BJS Open Original Article BACKGROUND: Aspartate aminotransferase/platelet ratio index (APRI) and albumin–bilirubin grade (ALBI) are validated prognostic indices implicated as predictors of postoperative liver dysfunction after hepatic resection. The aim of this study was to evaluate the relevance of the combined APRI/ALBI score for postoperative clinically meaningful outcomes. METHODS: Patients undergoing hepatectomy were included from the American College of Surgeons National Surgical Quality Improvement Program database. The association between APRI/ALBI score and postoperative grade C liver dysfunction, liver dysfunction-associated and overall 30-day mortality was assessed. RESULTS: A total of 12 055 patients undergoing hepatic resection from 2014 to 2017 with preoperative blood values and detailed 30-day postoperative outcomes were included (exploration cohort: January 2014 to December 2016; validation cohort: 2017). In the exploration cohort (8538 patients), the combination of both scores (APRI/ALBI) was significantly associated with postoperative grade C liver dysfunction, 30-day mortality, and liver dysfunction-associated 30-day mortality, and was superior to either score alone. The association with postoperative 30-day mortality was confirmed in multivariable analysis. A predictive model was generated using the exploration cohort. The predicted incidence of events closely followed the observed incidence in the validation cohort (3517 patients). Subgroup analyses of tumour types were used to generate disease-specific risk models to assess risk in different clinical scenarios. These findings informed development of a smartphone application (https://tellaprialbi.37binary.com). CONCLUSION: The predictive potential of the combined APRI/ALBI score for clinically relevant outcomes such as mortality was demonstrated. An evidence-based smartphone application will allow clinical translation and facilitation of risk assessment before hepatic resection using routine laboratory parameters. Oxford University Press 2021-01-17 /pmc/articles/PMC7893465/ /pubmed/33609383 http://dx.doi.org/10.1093/bjsopen/zraa043 Text en © The Author(s) 2021. Published by Oxford University Press on behalf of BJS Society Ltd. https://creativecommons.org/licenses/by/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) ), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Article
Starlinger, P
Ubl, D S
Hackl, H
Starlinger, J
Nagorney, D M
Smoot, R L
Habermann, E B
Cleary, S P
Combined APRI/ALBI score to predict mortality after hepatic resection
title Combined APRI/ALBI score to predict mortality after hepatic resection
title_full Combined APRI/ALBI score to predict mortality after hepatic resection
title_fullStr Combined APRI/ALBI score to predict mortality after hepatic resection
title_full_unstemmed Combined APRI/ALBI score to predict mortality after hepatic resection
title_short Combined APRI/ALBI score to predict mortality after hepatic resection
title_sort combined apri/albi score to predict mortality after hepatic resection
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7893465/
https://www.ncbi.nlm.nih.gov/pubmed/33609383
http://dx.doi.org/10.1093/bjsopen/zraa043
work_keys_str_mv AT starlingerp combinedaprialbiscoretopredictmortalityafterhepaticresection
AT ublds combinedaprialbiscoretopredictmortalityafterhepaticresection
AT hacklh combinedaprialbiscoretopredictmortalityafterhepaticresection
AT starlingerj combinedaprialbiscoretopredictmortalityafterhepaticresection
AT nagorneydm combinedaprialbiscoretopredictmortalityafterhepaticresection
AT smootrl combinedaprialbiscoretopredictmortalityafterhepaticresection
AT habermanneb combinedaprialbiscoretopredictmortalityafterhepaticresection
AT clearysp combinedaprialbiscoretopredictmortalityafterhepaticresection